|
|
CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication
|
|
|
|
|
نویسنده
|
price a.j. ,fletcher a.j. ,schaller t. ,elliott t. ,lee k. ,kewalramani v.n. ,chin j.w. ,towers g.j. ,james l.c.
|
منبع
|
plos pathogens - 2012 - دوره : 8 - شماره : 8
|
چکیده
|
The hiv-1 genome enters cells inside a shell comprised of capsid (ca) protein. variation in ca sequence alters hiv-1 infectivity and escape from host restriction factors. however,apart from the cyclophilin a-binding loop,ca has no known interfaces with which to interact with cellular cofactors. here we describe a novel protein-protein interface in the n-terminal domain of hiv-1 ca,determined by x-ray crystallography,which mediates both viral restriction and host cofactor dependence. the interface is highly conserved across lentiviruses and is accessible in the context of a hexameric lattice. mutation of the interface prevents binding to and restriction by cpsf6-358,a truncated cytosolic form of the rna processing factor,cleavage and polyadenylation specific factor 6 (cpsf6). furthermore,mutations that prevent cpsf6 binding also relieve dependence on nuclear entry cofactors tnpo3 and ranbp2. these results suggest that the hiv-1 capsid mediates direct host cofactor interactions to facilitate viral infection.
|
|
|
آدرس
|
medical research council laboratory of molecular biology,division of protein and nucleic acid chemistry,cambridge, United Kingdom, medical research council centre for medical molecular virology,division of infection and immunity,university college london,london, United Kingdom, medical research council centre for medical molecular virology,division of infection and immunity,university college london,london,united kingdom,department of infectious diseases,king's college london,guy's hospital,london, United Kingdom, medical research council laboratory of molecular biology,division of protein and nucleic acid chemistry,cambridge, United Kingdom, hiv drug resistance program,national cancer institute,frederick,md, United States, hiv drug resistance program,national cancer institute,frederick,md, United States, medical research council laboratory of molecular biology,division of protein and nucleic acid chemistry,cambridge, United Kingdom, medical research council centre for medical molecular virology,division of infection and immunity,university college london,london, United Kingdom, medical research council laboratory of molecular biology,division of protein and nucleic acid chemistry,cambridge, United Kingdom
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|